VOYA Investment Management
VIR icon

VOYA Investment Management’s Vir Biotechnology VIR Stock Holding History

VOYA Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
62,398
+46,073
+282% +$438K ﹤0.01% 1708
2026
Q1 		$146K Sell
16,325
-470
-3% -$3.75K ﹤0.01% 2155
2025
Q4 		$101K Hold
16,795
– – ﹤0.01% 2258
2025
Q3 		$95.9K Sell
16,795
-8,004
-32% -$40.9K ﹤0.01% 2310
2025
Q2 		$125K Buy
24,799
+363
+1% +$1.95K ﹤0.01% 2436
2025
Q1 		$158K Sell
24,436
-2,879
-11% -$25.6K ﹤0.01% 2330
2024
Q4 		$200K Sell
27,315
-2,382
-8% -$18.8K ﹤0.01% 2393
2024
Q3 		$222K Sell
29,697
-357
-1% -$3.1K ﹤0.01% 2426
2024
Q2 		$267K Buy
30,054
+2,225
+8% +$21.3K ﹤0.01% 2312
2024
Q1 		$282K Sell
27,829
-6,143
-18% -$62.6K ﹤0.01% 2280
2023
Q4 		$342K Buy
33,972
+440
+1% +$4.02K ﹤0.01% 2274
2023
Q3 		$314K Buy
33,532
+536
+2% +$7.64K ﹤0.01% 2282
2023
Q2 		$809K Sell
32,996
-2,542
-7% -$63.8K ﹤0.01% 1801
2023
Q1 		$827K Sell
35,538
-2,200
-6% -$56.3K ﹤0.01% 1768
2022
Q4 		$955K Sell
37,738
-4,544
-11% -$111K ﹤0.01% 1660
2022
Q3 		$815K Sell
42,282
-3,933
-9% -$100K ﹤0.01% 1737
2022
Q2 		$1.18M Buy
46,215
+22,496
+95% +$525K ﹤0.01% 1321
2022
Q1 		$610K Buy
23,719
+597
+3% +$17.7K ﹤0.01% 1788
2021
Q4 		$968K Sell
23,122
-271
-1% -$10.6K ﹤0.01% 1569
2021
Q3 		$1.02M Sell
23,393
-341
-1% -$14.8K ﹤0.01% 1558
2021
Q2 		$1.12M Buy
23,734
+265
+1% +$12K ﹤0.01% 1561
2021
Q1 		$1.2M Buy
23,469
+163
+0.7% +$8.79K ﹤0.01% 1470
2020
Q4 		$624K Buy
23,306
+5,158
+28% +$168K ﹤0.01% 1775
2020
Q3 		$623K Buy
18,148
+2,130
+13% +$91.7K ﹤0.01% 1533
2020
Q2 		$656K Buy
+16,018
New +$538K ﹤0.01% 1480

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VOYA Investment Management's VIR Position: Q2 2026 in Review

VOYA Investment Management increased its Vir Biotechnology (VIR) stake by 282% in Q2 2026, buying an estimated $438K and bringing the position to 62,398 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

VOYA Investment Management first reported a position in VIR in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.2M in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • VOYA Investment Management held 62,398 shares of Vir Biotechnology worth $636K as of Q2 2026.
  • VOYA Investment Management bought 46,073 Vir Biotechnology shares in Q2 2026, an estimated $438K.
  • Vir Biotechnology made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1708 holding.
  • VOYA Investment Management first reported a position in Vir Biotechnology in Q2 2020 and has held it in 25 quarters since.
  • VOYA Investment Management's Vir Biotechnology position peaked at $1.2M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.